NYSE ARCA | ETF
The ETF is designed to purchase a broad and diverse group of securities ofU. S. companies that the Advisor determines to be value stocks.
The Advisor considers companies of all market capitalizations for purchase by the Portfolio.
The Portfolio may purchase or sell futures contracts and options on futures contracts forU. S. equity securities and indices, to increase or decrease equity market exposure based on actual or expected cash inflows to or outflows from the Portfolio.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| JPM | JPMorgan Chase & Co | Financial Services | Banks - Diversified | 4.90% |
| XOM | Exxon Mobil Corp | Energy | Oil & Gas Integrated | 3.79% |
| BRK-B | Berkshire Hathaway Inc | Financial Services | Insurance - Diversified | 3.20% |
| CVX | Chevron Corp | Energy | Oil & Gas Integrated | 2.03% |
| META | Meta Platforms Inc. | Communication Services | Internet Content & Information | 1.84% |
| CSCO | Cisco Systems Inc | Technology | Communication Equipment | 1.47% |
| BAC | Bank of America Corp | Financial Services | Banks - Diversified | 1.45% |
| CMCSA | Comcast Corp | Communication Services | Telecom Services | 1.44% |
| VZ | Verizon Communications Inc | Communication Services | Telecom Services | 1.27% |
| WFC | Wells Fargo & Company | Financial Services | Banks - Diversified | 1.24% |
| T | AT&T Inc | Communication Services | Telecom Services | 1.20% |
| CRM | Salesforce.com Inc | Technology | Software - Application | 1.18% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 1.15% |
| COP | ConocoPhillips | Energy | Oil & Gas E&P | 1.12% |
| GS | Goldman Sachs Group Inc | Financial Services | Capital Markets | 1.07% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 0.96% |
| MS | Morgan Stanley | Financial Services | Capital Markets | 0.95% |
| TMUS | T-Mobile US Inc | Communication Services | Telecom Services | 0.93% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 0.89% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 0.78% |